Sam Genway

Sam has an academic research background in theoretical physics, specialising in the simulation of quantum systems. He has spent seven years as a consultant working in data-driven R&D and has led projects at the forefront of cutting-edge technologies such as artificial intelligence and quantum computing. Sam has worked with several of the largest pharmaceutical companies on challenges such as AI-driven de novo drug design and virtual screening. Within Capgemini Engineering, he has spent the last two years leading an in-house technology accelerator programme, undertaking research projects in the applications of developing technologies such as reinforcement learning and quantum optimisation.